KLK3 and neoplasm: Tumor markers in current clinical use, such as carcinoembryonic antigen, prostate-specific antigen, HER-2, and mucins (e.g., CA 19.9, CA 125, and CA 15.3), are all glycoproteins that are either membrane-associated or secreted to the serum [280-282].